Clinical trials
Recruiting Phase 3 trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
108 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 11 |
| 2024 | 24 |
| 2025 | 42 |
| 2026 | 17 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 108 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 17 |
| AstraZeneca | 13 |
| Novartis Pharmaceuticals | 9 |
| Chinese University of Hong Kong | 7 |
| The University of Hong Kong | 7 |
| Boehringer Ingelheim | 6 |
| Amgen | 4 |
| Janssen Research & Development, LLC | 4 |
| GlaxoSmithKline | 3 |
| Hoffmann-La Roche | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 14 |
| Breast Neoplasms | 12 |
| Lung Neoplasms | 7 |
| Non-alcoholic Fatty Liver Disease | 5 |
| Prostatic Neoplasms | 5 |
| Obesity | 4 |
| Postoperative Pain | 4 |
| Colorectal Neoplasms | 3 |
| Fatty Liver | 3 |
| Neoplasms | 3 |
Trials
Showing 1 to 25 of 108. Each trial links to its page on Pharma Observatory.
8 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.